Mike Mackness

6.2k total citations · 1 hit paper
89 papers, 4.9k citations indexed

About

Mike Mackness is a scholar working on Clinical Biochemistry, Plant Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mike Mackness has authored 89 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Clinical Biochemistry, 27 papers in Plant Science and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mike Mackness's work include Paraoxonase enzyme and polymorphisms (47 papers), Cynara cardunculus studies (22 papers) and Lipoproteins and Cardiovascular Health (19 papers). Mike Mackness is often cited by papers focused on Paraoxonase enzyme and polymorphisms (47 papers), Cynara cardunculus studies (22 papers) and Lipoproteins and Cardiovascular Health (19 papers). Mike Mackness collaborates with scholars based in United Kingdom, United States and Spain. Mike Mackness's co-authors include Bharti Mackness, Paul N. Durrington, C.H. Walker, Sharon Arrol, Deepak Bhatnagar, Caroline A. Abbott, David Hine, Wim Verreth, Paul Holvoet and Rozenn Quarck and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Mike Mackness

88 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paraoxonase and Atherosclerosis

2001 668 citations Paul N. Durrington, Bharti Mackness et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Mackness United Kingdom	38	2.7k	1.3k	1.1k	1.1k	1.0k	89	4.9k
Sharon Arrol United Kingdom	29	2.9k 1.1×	1.4k 1.0×	1.1k 1.0×	996 0.9×	1.0k 1.0×	43	4.7k
Bharti Mackness United Kingdom	46	6.0k 2.2×	2.9k 2.2×	2.1k 1.9×	992 0.9×	1.0k 1.0×	93	7.8k
Michael I. Mackness United Kingdom	42	5.5k 2.0×	2.7k 2.0×	2.0k 1.9×	2.7k 2.5×	2.6k 2.6×	85	10.2k
Marielle Kaplan Israel	32	389 0.1×	631 0.5×	310 0.3×	802 0.7×	833 0.8×	72	4.1k
H W Eckerson United States	12	1.1k 0.4×	561 0.4×	519 0.5×	209 0.2×	137 0.1×	14	1.9k
Arie van Tol Netherlands	51	709 0.3×	227 0.2×	329 0.3×	3.8k 3.5×	4.1k 4.0×	201	8.3k
Franklin H. Epstein United States	6	452 0.2×	213 0.2×	272 0.2×	1.4k 1.3×	676 0.7×	7	6.1k
Peter Winocour United Kingdom	29	599 0.2×	189 0.1×	259 0.2×	693 0.6×	1.3k 1.3×	118	3.2k
Charles van Ypersele de Strihou Belgium	43	1.9k 0.7×	75 0.1×	211 0.2×	562 0.5×	933 0.9×	99	6.0k
Mariann Harangi Hungary	23	548 0.2×	255 0.2×	297 0.3×	331 0.3×	337 0.3×	117	1.8k

Countries citing papers authored by Mike Mackness

Since Specialization

Citations

This map shows the geographic impact of Mike Mackness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Mackness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Mackness more than expected).

Fields of papers citing papers by Mike Mackness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Mackness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Mackness. The network helps show where Mike Mackness may publish in the future.

Co-authorship network of co-authors of Mike Mackness

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Mackness. A scholar is included among the top collaborators of Mike Mackness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Mackness. Mike Mackness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rojas‐García, Aurora Elizabeth, Mike Mackness, Briscia Socorro Barrón-Vivanco, et al.. (2019). Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake. Nutrition Metabolism and Cardiovascular Diseases. 30(1). 40–48. 15 indexed citations

Rojas‐García, Aurora Elizabeth, Mike Mackness, Yael Yvette Bernal-Hernández, et al.. (2017). Transcriptional regulation of human Paraoxonase 1 by nuclear receptors. Chemico-Biological Interactions. 268. 77–84. 28 indexed citations

Mackness, Bharti, Wajdi Turkie, & Mike Mackness. (2013). Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease. Archives of Medical Science. 1(1). 8–13. 28 indexed citations

Mackness, Mike & Bharti Mackness. (2013). Targeting paraoxonase-1 in atherosclerosis. Expert Opinion on Therapeutic Targets. 17(7). 829–837. 43 indexed citations

Mackness, Mike & Bharti Mackness. (2011). Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity. Clinical Biochemistry. 44(14-15). 1270–1271. 4 indexed citations

Patel, Jay, Muriel Caslake, Avni Vyas, et al.. (2009). Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations. Atherosclerosis. 209(2). 579–584. 16 indexed citations

Mackness, Bharti, et al.. (2008). Glycation of paraoxonase‐1 inhibits its activity and impairs the ability of high‐density lipoprotein to metabolize membrane lipid hydroperoxides. Diabetic Medicine. 25(9). 1049–1055. 94 indexed citations

Guns, Pieter‐Jan, Tim Van Assche, Wim Verreth, et al.. (2007). Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E‐deficient mice with pre‐existing atherosclerosis. British Journal of Pharmacology. 153(3). 508–516. 45 indexed citations

Povey, Andrew C., Francine Jury, Stuart Thomson, et al.. (2007). GST, CYPandPON1polymorphisms in farmers attributing ill health to organophosphate-containing sheep dip. Biomarkers. 12(2). 188–202. 11 indexed citations

10.

Patel, Jeetesh V., Avni Vyas, J.K. Cruickshank, et al.. (2005). Impact of migration on coronary heart disease risk factors: Comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis. 185(2). 297–306. 183 indexed citations

11.

Thomason, Margaret J., Helen M. Colhoun, Shona Livingstone, et al.. (2004). Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. Diabetic Medicine. 21(8). 901–905. 15 indexed citations

12.

Mackness, Mike, Paul N. Durrington, & Bharti Mackness. (2004). Paraoxonase 1 activity, concentration and genotype in cardiovascular disease. Current Opinion in Lipidology. 15(4). 399–404. 88 indexed citations

13.

Mackness, Bharti, Paul N. Durrington, Andrew C. Povey, et al.. (2003). Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics. 13(2). 81–88. 64 indexed citations

14.

Colhoun, Helen M., Margaret J. Thomason, Mike Mackness, et al.. (2002). Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. Diabetic Medicine. 19(3). 201–211. 77 indexed citations

15.

Mackness, Bharti, Paul N. Durrington, Andrew J.M. Boulton, David Hine, & Mike Mackness. (2002). Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. European Journal of Clinical Investigation. 32(4). 259–264. 108 indexed citations

16.

Bolton, C., L G Downs, Jeremy Dwight, et al.. (2001). Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro‐inflammatory cytokines. Nephrology Dialysis Transplantation. 16(6). 1189–1197. 233 indexed citations

17.

Sweetnam, P M, C. Bolton, L G Downs, et al.. (2000). Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study. European Journal of Clinical Investigation. 30(11). 947–956. 41 indexed citations

18.

Brown, John H., Colin D. Short, Deepak Bhatnagar, et al.. (1997). Influence of Immunosuppressive Therapy on Lipoprotein(a) and Other Lipoproteins following Renal Transplantation. Nephron. 75(3). 277–282. 37 indexed citations

19.

Mackness, Mike, et al.. (1995). Susceptibility of low and high density lipoproteins from subjects with diabetes to in vitro oxidative modification. Atherosclerosis. 115. S23–S23. 1 indexed citations

20.

Bhatnagar, Deepak, P.N. Durrington, Keith M. Channon, H. Prais, & Mike Mackness. (1993). Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 98(1). 25–32. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact